Ki-CONNECT Now
Access
EN
Our vision
Facilities
Our team
What we do
Get in touch
Ki-CONNECT Now
Access
EN
Ki-CONNECT Now
Apr. 23, 2025
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
Ki-CONNECT Now一覧へ
